ATE473446T1 - Verfahren und testvorrichtungen zur unterscheidung verschiedener formen von krankheiten und leiden, die durch thrombocytopenia und/oder durch spontane interaktionen zwischen dem von-willebrand-faktor und plättchen gekennzeichnet sind - Google Patents
Verfahren und testvorrichtungen zur unterscheidung verschiedener formen von krankheiten und leiden, die durch thrombocytopenia und/oder durch spontane interaktionen zwischen dem von-willebrand-faktor und plättchen gekennzeichnet sindInfo
- Publication number
- ATE473446T1 ATE473446T1 AT06701801T AT06701801T ATE473446T1 AT E473446 T1 ATE473446 T1 AT E473446T1 AT 06701801 T AT06701801 T AT 06701801T AT 06701801 T AT06701801 T AT 06701801T AT E473446 T1 ATE473446 T1 AT E473446T1
- Authority
- AT
- Austria
- Prior art keywords
- diseases
- thrombocytopenia
- von willebrand
- willebrand factor
- vwf
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
- G01N2333/755—Factors VIII, e.g. factor VIII C [AHF], factor VIII Ag [VWF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/22—Haematology
- G01N2800/222—Platelet disorders
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64441405P | 2005-01-14 | 2005-01-14 | |
PCT/EP2006/000273 WO2006074947A2 (en) | 2005-01-14 | 2006-01-13 | METHODS AND ASSAYS FOR DISTINGUISHING BETWEEN DIFFERENT FORMS OF DISEASES AND DISORDERS CHARACTERIZED BY THROMBOCYTOPENIA AND/OR BY SPONTANEOUS INTERACTION BETWEEN VON WILLEBRAND FACTOR (vWF) AND PLATELETS |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE473446T1 true ATE473446T1 (de) | 2010-07-15 |
Family
ID=36593150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06701801T ATE473446T1 (de) | 2005-01-14 | 2006-01-13 | Verfahren und testvorrichtungen zur unterscheidung verschiedener formen von krankheiten und leiden, die durch thrombocytopenia und/oder durch spontane interaktionen zwischen dem von-willebrand-faktor und plättchen gekennzeichnet sind |
Country Status (13)
Country | Link |
---|---|
US (1) | US7939277B2 (de) |
EP (1) | EP1836500B1 (de) |
JP (1) | JP4829897B2 (de) |
AT (1) | ATE473446T1 (de) |
AU (1) | AU2006205900B8 (de) |
CA (1) | CA2593328C (de) |
DE (1) | DE602006015281D1 (de) |
DK (1) | DK1836500T3 (de) |
ES (1) | ES2347908T3 (de) |
PL (1) | PL1836500T3 (de) |
PT (1) | PT1836500E (de) |
SI (1) | SI1836500T1 (de) |
WO (1) | WO2006074947A2 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003251238A1 (en) * | 2002-08-07 | 2004-02-25 | Umc Utrecht Holding B.V. | Modulation of platelet adhesion based on the surface exposed beta-switch loop of platelet glycoprotein ib-alpha |
US9453251B2 (en) | 2002-10-08 | 2016-09-27 | Pfenex Inc. | Expression of mammalian proteins in Pseudomonas fluorescens |
CA2512545C (en) | 2003-01-10 | 2015-06-30 | Karen Silence | Recombinant vhh single domain antibody from camelidae against von willebrand factor (vwf) |
BRPI0513826A2 (pt) | 2004-07-26 | 2010-06-22 | Dow Global Technologies Inc | processo para expressão de proteìna melhorada através de engenharia de cepa |
EP1836500B1 (de) | 2005-01-14 | 2010-07-07 | Ablynx N.V. | Verfahren und testvorrichtungen zur unterscheidung verschiedener formen von krankheiten und leiden, die durch thrombocytopenia und/oder durch spontane interaktionen zwischen dem von-willebrand-faktor und plättchen gekennzeichnet sind |
CA2608873C (en) | 2005-05-20 | 2017-04-25 | Ablynx Nv | Single domain vhh antibodies against von willebrand factor |
WO2008049881A2 (en) * | 2006-10-25 | 2008-05-02 | Umc Utrecht Holding Bv | Polypeptides and pharmaceutical compositions comprising the same for the prevention and treatment of complications associated with infectious diseases |
CN101688213A (zh) | 2007-04-27 | 2010-03-31 | 陶氏环球技术公司 | 用于快速筛选微生物宿主以鉴定某些在表达异源蛋白质方面具有改善的产量和/或质量的菌株的方法 |
US9580719B2 (en) | 2007-04-27 | 2017-02-28 | Pfenex, Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
JP2011518772A (ja) * | 2008-03-21 | 2011-06-30 | アブリンクス エン.ヴェー. | フォンウィルブランド因子特異的結合因子及びこれらに関する使用方法 |
GB0809069D0 (en) | 2008-05-19 | 2008-06-25 | Univ Leuven Kath | Gene signatures |
US8444976B2 (en) | 2008-07-02 | 2013-05-21 | Argen-X B.V. | Antigen binding polypeptides |
HUE027112T2 (en) * | 2008-12-04 | 2016-08-29 | Inserm (Institut Nat De La Sante Et De La Rech Medicale) | Procedure for producing platelets |
US20160095939A1 (en) | 2014-10-07 | 2016-04-07 | Immunomedics, Inc. | Neoadjuvant use of antibody-drug conjugates |
US9265834B2 (en) | 2009-03-05 | 2016-02-23 | Ablynx N.V. | Stable formulations of polypeptides and uses thereof |
US10005830B2 (en) | 2009-03-05 | 2018-06-26 | Ablynx N.V. | Antigen binding dimer-complexes, methods of making/avoiding and uses thereof |
US9884117B2 (en) * | 2009-09-03 | 2018-02-06 | Ablynx N.V. | Stable formulations of polypeptides and uses thereof |
CN102648212B (zh) | 2009-11-13 | 2014-12-03 | 基立福疗法公司 | 包含冯维勒布兰德因子(vWF)的制剂及其相关制备方法、试剂盒和用途 |
NL1040254C2 (en) | 2013-05-17 | 2014-11-24 | Ablynx Nv | Stable formulations of immunoglobulin single variable domains and uses thereof. |
NL2013007B1 (en) | 2014-06-16 | 2016-07-05 | Ablynx Nv | Methods of treating TTP with immunoglobulin single variable domains and uses thereof. |
CA2981543A1 (en) | 2015-04-22 | 2016-10-27 | Immunomedics, Inc. | Isolation, detection, diagnosis and/or characterization of circulating trop-2-positive cancer cells |
EP3316885B1 (de) | 2015-07-01 | 2021-06-23 | Immunomedics, Inc. | Antikörper-sn-38-immunkonjugate mit einem cl2a-linker |
RU2599021C1 (ru) * | 2015-07-27 | 2016-10-10 | Федеральное государственное бюджетное учреждение науки "Кировский научно-исследовательский институт гематологии и переливания крови Федерального медико-биологического агентства" | Способ прогнозирования течения иммунной тромбоцитопении после спленэктомии по массе cd4+ т-лимфоцитов селезенки |
MX2020008294A (es) | 2018-02-06 | 2020-11-18 | Ablynx Nv | Metodos de tratamiento de episodio inicial de ttp con dominios variables simples de inmunoglobulina. |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5238919A (en) | 1986-05-30 | 1993-08-24 | Scipps Clinic And Research Foundation | Peptides that inhibit von Willebrand Factor binding to the platelet SPIB receptor |
US5200510A (en) | 1987-06-16 | 1993-04-06 | Zymogenetics, Inc. | Method for purifying factor viii:c, von willebrand factor and complexes thereof |
US5770198A (en) | 1988-05-18 | 1998-06-23 | The Research Foundation Of The State Of New York | Platelet-specific chimeric 7E3 immunoglobulin |
JP2919890B2 (ja) | 1988-11-11 | 1999-07-19 | メディカル リサーチ カウンスル | 単一ドメインリガンド、そのリガンドからなる受容体、その製造方法、ならびにそのリガンドおよび受容体の使用 |
GB8905400D0 (en) | 1989-03-09 | 1989-04-19 | Jonker Margreet | Medicaments |
EP0617706B1 (de) | 1991-11-25 | 2001-10-17 | Enzon, Inc. | Multivalente antigen-bindende proteine |
PT1498427E (pt) | 1992-08-21 | 2010-03-22 | Univ Bruxelles | Imunoglobulinas desprovidas de cadeias leves |
EP0628078B1 (de) | 1992-12-11 | 1999-12-08 | The Dow Chemical Company | Multivalente einkettige Antikörper |
DK0698097T3 (da) | 1993-04-29 | 2001-10-08 | Unilever Nv | Produktion af antistoffer eller (funktionaliserede) fragmenter deraf afledt af Camelidae-immunoglobuliner med tung kæde |
US5670132A (en) | 1994-09-20 | 1997-09-23 | Immunomedics, Inc. | Modified radioantibody fragments for reduced renal uptake |
KR100406072B1 (ko) | 1994-11-30 | 2004-03-30 | 아지노모토 가부시키가이샤 | 항혈전제 및 항-폰빌레브란트인자 모노클로날항체 |
EP0739981A1 (de) | 1995-04-25 | 1996-10-30 | Vrije Universiteit Brussel | Variable Fragmente von Immunglobulinen-Verwendung zur therapeutischen oder veterinären Zwecken |
DK0894135T3 (da) | 1996-04-04 | 2004-12-06 | Unilever Nv | Multivalent og multispecifikt antigenbindingsprotein |
CA2258518C (en) | 1996-06-27 | 2011-11-22 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Recognition molecules interacting specifically with the active site or cleft of a target molecule |
EP1015480A2 (de) | 1997-08-18 | 2000-07-05 | Innogenetics N.V. | Interferon gamma bindende moleküle zur behandlung von septischem schock, cachexia, immunkrankheiten und hautkrankheiten |
ATE461282T1 (de) | 1997-10-27 | 2010-04-15 | Bac Ip Bv | Multivalente antigenbindende proteine |
ATE535154T1 (de) | 1998-03-12 | 2011-12-15 | Vhsquared Ltd | Produkten die inaktivierte hefen oder schimmel enthalten, die auf ihrer aussenoberfläche aktive antikörper haben |
HUP9900956A2 (hu) | 1998-04-09 | 2002-04-29 | Aventis Pharma Deutschland Gmbh. | Egyláncú, több antigéntkötőhely kialakítására képes molekulák, előállításuk és alkalmazásuk |
US6228360B1 (en) | 1998-08-19 | 2001-05-08 | Ajinomoto Co., Inc. | Antithrombotic agent and humanized anti-von Willebrand factor monoclonal antibody |
CA2344606A1 (en) | 1998-10-23 | 2000-05-04 | Huabing Yuan | Conformation-specific anti-von willebrand factor antibodies |
EP1002861A1 (de) | 1998-10-26 | 2000-05-24 | Unilever Plc | Antigenbindungsproteine mit einer Kopplung, die die strukturelle Beweglichkeit einschränkt |
WO2000043507A1 (en) | 1999-01-19 | 2000-07-27 | Unilever Plc | Method for producing antibody fragments |
US6419934B1 (en) | 1999-02-24 | 2002-07-16 | Edward L. Tobinick | TNF modulators for treating neurological disorders associated with viral infection |
EP2309275A1 (de) | 1999-07-05 | 2011-04-13 | K.U.Leuven Research & Development | Von Willebrand-Faktor-Aktivitätsnachweis |
CA2380443C (en) | 2000-05-26 | 2013-03-12 | Ginette Dubuc | Single-domain antigen-binding antibody fragments derived from llama antibodies |
US7943129B2 (en) | 2000-05-26 | 2011-05-17 | National Research Council Of Canada | Single-domain brain-targeting antibody fragments derived from llama antibodies |
US6699473B2 (en) | 2000-10-13 | 2004-03-02 | Uab Research Foundation | Human anti-epidermal growth factor receptor single-chain antibodies |
GB0031448D0 (en) | 2000-12-22 | 2001-02-07 | Leuven K U Res & Dev | Inhibition of the vWF-collagen interaction by anti-human vWF monoclonal antibody (82D6A3) results in abolition of in vivo arterial platelet thrombus formation |
US7371849B2 (en) | 2001-09-13 | 2008-05-13 | Institute For Antibodies Co., Ltd. | Methods of constructing camel antibody libraries |
JP2006512895A (ja) | 2002-06-28 | 2006-04-20 | ドマンティス リミテッド | リガンド |
US20050136056A1 (en) | 2002-07-29 | 2005-06-23 | Shunsuke Kageyama | Pharmaceutical composition for the treatment of thrombocytopenia |
AU2003251238A1 (en) | 2002-08-07 | 2004-02-25 | Umc Utrecht Holding B.V. | Modulation of platelet adhesion based on the surface exposed beta-switch loop of platelet glycoprotein ib-alpha |
EP1900753B1 (de) | 2002-11-08 | 2017-08-09 | Ablynx N.V. | Verfahren zur Verabreichung therapeutischer Polypeptide und Polypeptide dafür |
US20060228355A1 (en) | 2003-11-07 | 2006-10-12 | Toon Laeremans | Camelidae single domain antibodies vhh directed against epidermal growth factor receptor and uses therefor |
EP2267032A3 (de) | 2002-11-08 | 2011-11-09 | Ablynx N.V. | Verfahren zur Verabreichung therapeutischer Polypeptide und Polypeptide dafür |
CA2512545C (en) | 2003-01-10 | 2015-06-30 | Karen Silence | Recombinant vhh single domain antibody from camelidae against von willebrand factor (vwf) |
PL1639011T3 (pl) | 2003-06-30 | 2009-05-29 | Domantis Ltd | Pegilowane przeciwciała jednodomenowe (dAb) |
EP1836500B1 (de) | 2005-01-14 | 2010-07-07 | Ablynx N.V. | Verfahren und testvorrichtungen zur unterscheidung verschiedener formen von krankheiten und leiden, die durch thrombocytopenia und/oder durch spontane interaktionen zwischen dem von-willebrand-faktor und plättchen gekennzeichnet sind |
CA2608873C (en) | 2005-05-20 | 2017-04-25 | Ablynx Nv | Single domain vhh antibodies against von willebrand factor |
WO2008049881A2 (en) * | 2006-10-25 | 2008-05-02 | Umc Utrecht Holding Bv | Polypeptides and pharmaceutical compositions comprising the same for the prevention and treatment of complications associated with infectious diseases |
-
2006
- 2006-01-13 EP EP06701801A patent/EP1836500B1/de active Active
- 2006-01-13 DE DE602006015281T patent/DE602006015281D1/de active Active
- 2006-01-13 DK DK06701801.0T patent/DK1836500T3/da active
- 2006-01-13 US US11/795,162 patent/US7939277B2/en active Active
- 2006-01-13 AT AT06701801T patent/ATE473446T1/de active
- 2006-01-13 AU AU2006205900A patent/AU2006205900B8/en active Active
- 2006-01-13 CA CA2593328A patent/CA2593328C/en not_active Expired - Fee Related
- 2006-01-13 JP JP2007550764A patent/JP4829897B2/ja active Active
- 2006-01-13 PT PT06701801T patent/PT1836500E/pt unknown
- 2006-01-13 SI SI200630783T patent/SI1836500T1/sl unknown
- 2006-01-13 WO PCT/EP2006/000273 patent/WO2006074947A2/en active Application Filing
- 2006-01-13 PL PL06701801T patent/PL1836500T3/pl unknown
- 2006-01-13 ES ES06701801T patent/ES2347908T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
SI1836500T1 (sl) | 2010-11-30 |
EP1836500A2 (de) | 2007-09-26 |
PL1836500T3 (pl) | 2010-12-31 |
ES2347908T3 (es) | 2010-11-25 |
AU2006205900A1 (en) | 2006-07-20 |
CA2593328C (en) | 2018-02-06 |
US7939277B2 (en) | 2011-05-10 |
WO2006074947A2 (en) | 2006-07-20 |
US20080096223A1 (en) | 2008-04-24 |
AU2006205900A8 (en) | 2012-04-05 |
DE602006015281D1 (de) | 2010-08-19 |
EP1836500B1 (de) | 2010-07-07 |
AU2006205900B8 (en) | 2012-04-05 |
AU2006205900B2 (en) | 2011-12-08 |
WO2006074947A3 (en) | 2006-09-14 |
JP2008527358A (ja) | 2008-07-24 |
JP4829897B2 (ja) | 2011-12-07 |
CA2593328A1 (en) | 2006-07-20 |
PT1836500E (pt) | 2010-09-28 |
DK1836500T3 (da) | 2010-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE473446T1 (de) | Verfahren und testvorrichtungen zur unterscheidung verschiedener formen von krankheiten und leiden, die durch thrombocytopenia und/oder durch spontane interaktionen zwischen dem von-willebrand-faktor und plättchen gekennzeichnet sind | |
ATE410687T1 (de) | Vorrichtung und verfahren zur simultanen durchführung von blutgruppenbestimmung, serumgegenprobe und antikörpersuch-test | |
ATE511656T1 (de) | Verfahren zur risikobewertung von herzeingriffen auf gdf-15-basis | |
ATE514092T1 (de) | Vorrichtung und verfahren zur simultanen bestimmung von blutgruppenantigenen | |
WO2007140962A3 (en) | Improved measurement of vitamin d | |
HK1090696A1 (en) | Neurotoxic amino acid or neurotoxic derivative thereof associated with neurological disorders | |
ATE470862T1 (de) | Vorrichtung und verfahren zur unterscheidung zwischen akuter und chronischer myokardial- nekrose bei symptomatischen patienten | |
ATE493649T1 (de) | Verfahren zur diagnose von polyzystischer nierenkrankheit | |
ATE554168T1 (de) | Integriertes mikrofluidisches bauteil zum aufreinigen von analytmolekülen sowie verfahren zum aufreinigen | |
HUP0202532A2 (hu) | Ko-stimulátor szignál-transzdukciós molekula (AILIM) elleni humán monoklonális antitest és gyógyászati alkalmazása | |
DE60233949D1 (de) | Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon | |
BRPI0606306A2 (pt) | sistema e método para previsão de eventos adversos durante o tratamento de desordens psicológicas e neurológicas | |
DE502006008028D1 (de) | Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen | |
WO2005098433A3 (en) | Diagnostic assays for alzheimer’s disease | |
DE602004024539D1 (de) | Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben | |
EP1977234A4 (de) | Moleküle zur behandlung von lungenerkrankungen mit einer immunreaktion mit verbindungsgewebe in der lunge | |
ATE550668T1 (de) | Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis | |
ATE473448T1 (de) | Verfahren zur diagnose von herz-kreislauf- krankheiten | |
ATE553127T1 (de) | Oligoklonale anti-clusterin-antikörper zur diagnose und vorhersage der aggressivität von tumoren, diagnostisches verfahren und damit in zusammenhang stehende kits | |
DE60317070D1 (de) | Verfahren zur diagnose von multipler sklerose | |
DE602006015221D1 (de) | Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression | |
DE502006004301D1 (de) | Diagnose von allergischen erkrankungen, atopischen erkrankungen und/oder autoimmunerkrankungen durch nachweis von autoantikörpern gegen cd28 in humanem serum | |
ATE517345T1 (de) | Verfahren zur analyse von proben mit einem mittel zur gasentwicklung | |
DE602004027534D1 (de) | Diagnostische verfahren für therapeutische verbindungen sowie verfahren zur überwachung der azathioprin-therapie | |
ATE509270T1 (de) | Aus blutplättchen gewonnene mikropartikel als neue diagnosemarker für eine herz-kreislauf- erkrankung |